APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biomanufacturing in Bio-based Materials

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biomanufacturing in Bio-based Materials Market Outlook and Growth Opportunities 2026

6 March 2026211 pages

Choose your research edition.

Industry ResearchBiomanufacturing in Bio-based Materials Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Biomanufacturing in Bio-based Materials Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Biomanufacturing in Bio-based Materials Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biomanufacturing in Bio-based Materials Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Biomanufacturing in Bio-based Materials Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Biomanufacturing in Bio-based Materials market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biomanufacturing in Bio-based Materials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biomanufacturing in Bio-based Materials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biomanufacturing in Bio-based Materials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biomanufacturing in Bio-based Materials market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biomanufacturing in Bio-based Materials market include Braskem, NatureWorks, Tate & Lyle, Fufeng Group, Meihua Group, Bloomage Biotech, Anhui BBCA Group, Lushang Freda and Total Corbion, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Biomanufacturing in Bio-based Materials market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biomanufacturing in Bio-based Materials and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biomanufacturing in Bio-based Materials revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biomanufacturing in Bio-based Materials market.

Biomanufacturing in Bio-based Materials Segment by Company

Braskem

NatureWorks

Tate & Lyle

Fufeng Group

Meihua Group

Bloomage Biotech

Anhui BBCA Group

Lushang Freda

Total Corbion

Zhejiang Hisun Biomaterials

Pharmacosmos A/S

Danimer Scientific

Kingfa Sci.&Tech

Kewpie Corporation

Vedan Biotechnology

Giant Biogene

Contipro Inc.

Shandong Topscience Biotech

Blue Ridge Tunhe

JNC Corporation

NAGASE

CJ Bio

Bluepha

Givaudan

RWDC Industries

Toyobo

PTT MCC Biochem

TianAn Biologic Materials Co

Kaneka

Jiangsu JLand Biotech

Jiangsu Chuangjian Medical Technology

Cathay Biotech Inc.

Zhejiang Shengda Bio-Pharm

DANCHENG CAIXIN SUGAR INDUSTRY

CanSinoBIO

AMSilk GmbH

Shandong AWA Biopharm

Shandong Mimei Biotechnology

Juyou Bio-Technology

Shanghai Techwell Biopharmacieutical

Jinpu Nuoan Biotechnology

Jinyang Pharmaceutical

Ningxia Eppen Biotech

Kuraray

Shanxi Jinbo Bio-pharmaceutical

Wuhu Interferon

Evonik

TS-Biotech

Nanjing XuanKai Biotechnology

HTL Biotechnology

Biomanufacturing in Bio-based Materials Segment by Type

Polysaccharide Polymers

Protein Polymers

Polyester Polymers

Others

Biomanufacturing in Bio-based Materials Segment by Application

Food & Beverage

Daily Chemicals

Medical

Packaging

Textiles

Automotive Industry

Other

Biomanufacturing in Bio-based Materials Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biomanufacturing in Bio-based Materials status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biomanufacturing in Bio-based Materials key companies, revenue, market share, and recent developments.

3. To split the Biomanufacturing in Bio-based Materials breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biomanufacturing in Bio-based Materials market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biomanufacturing in Bio-based Materials significant trends, drivers, influence factors in global and regions.

6. To analyze Biomanufacturing in Bio-based Materials competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomanufacturing in Bio-based Materials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomanufacturing in Bio-based Materials and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomanufacturing in Bio-based Materials.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biomanufacturing in Bio-based Materials industry.

Chapter 3: Detailed analysis of Biomanufacturing in Bio-based Materials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biomanufacturing in Bio-based Materials in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biomanufacturing in Bio-based Materials in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biomanufacturing in Bio-based Materials Industry Trends Table 2. Biomanufacturing in Bio-based Materials Industry Drivers Table 3. Biomanufacturing in Bio-based Materials Industry Opportunities and Challenges Table 4. Biomanufacturing in Bio-based Materials Industry Restraints Table 5. Global Biomanufacturing in Bio-based Materials Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biomanufacturing in Bio-based Materials Revenue Share by Company (2021-2026) Table 7. Global Biomanufacturing in Bio-based Materials Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biomanufacturing in Bio-based Materials Key Company Manufacturing Base & Headquarters Table 9. Global Biomanufacturing in Bio-based Materials Company, Product Type & Application Table 10. Global Biomanufacturing in Bio-based Materials Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biomanufacturing in Bio-based Materials by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Polysaccharide Polymers Table 15. Significant Companies of Protein Polymers Table 16. Significant Companies of Polyester Polymers Table 17. Significant Companies of Others Table 18. Global Biomanufacturing in Bio-based Materials Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Biomanufacturing in Bio-based Materials Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Biomanufacturing in Bio-based Materials Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Biomanufacturing in Bio-based Materials Sales Value Share by Type (2021-2026) Table 22. Global Biomanufacturing in Bio-based Materials Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Food & Beverage Table 24. Significant Companies of Daily Chemicals Table 25. Significant Companies of Medical Table 26. Significant Companies of Packaging Table 27. Significant Companies of Textiles Table 28. Significant Companies of Automotive Industry Table 29. Significant Companies of Other Table 30. Global Biomanufacturing in Bio-based Materials Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Biomanufacturing in Bio-based Materials Sales Value by Application (2021-2026) & (US$ Million) Table 32. Global Biomanufacturing in Bio-based Materials Sales Value by Application (2027-2032) & (US$ Million) Table 33. Global Biomanufacturing in Bio-based Materials Sales Value Share by Application (2021-2026) Table 34. Global Biomanufacturing in Bio-based Materials Sales Value Share by Application (2027-2032) Table 35. Global Biomanufacturing in Bio-based Materials Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Biomanufacturing in Bio-based Materials Sales Value by Region (2021-2026) & (US$ Million) Table 37. Global Biomanufacturing in Bio-based Materials Sales Value Share by Region (2021-2026) Table 38. Global Biomanufacturing in Bio-based Materials Sales Value by Region (2027-2032) & (US$ Million) Table 39. Global Biomanufacturing in Bio-based Materials Sales Value Share by Region (2027-2032) Table 40. Global Biomanufacturing in Bio-based Materials Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Biomanufacturing in Bio-based Materials Sales Value by Country (2021-2026) & (US$ Million) Table 42. Global Biomanufacturing in Bio-based Materials Sales Value Market Share by Country (2021-2026) Table 43. Global Biomanufacturing in Bio-based Materials Sales Value by Country (2027-2032) & (US$ Million) Table 44. Global Biomanufacturing in Bio-based Materials Sales Value Market Share by Country (2027-2032) Table 45. Braskem Company Information Table 46. Braskem Business Overview Table 47. Braskem Biomanufacturing in Bio-based Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Braskem Biomanufacturing in Bio-based Materials Product Portfolio Table 49. Braskem Recent Development Table 50. NatureWorks Company Information Table 51. NatureWorks Business Overview Table 52. NatureWorks Biomanufacturing in Bio-based Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. NatureWorks Biomanufacturing in Bio-based Materials Product Portfolio Table 54. NatureWorks Recent Development Table 55. Tate & Lyle Company Information Table 56. Tate & Lyle Business Overview Table 57. Tate & Lyle Biomanufacturing in Bio-based Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Tate & Lyle Biomanufacturing in Bio-based Materials Product Portfolio Table 59. Tate & Lyle Recent Development Table 60. Fufeng Group Company Information Table 61. Fufeng Group Business Overview Table 62. Fufeng Group Biomanufacturing in Bio-based Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Fufeng Group Biomanufacturing in Bio-based Materials Product Portfolio Table 64. Fufeng Group Recent Development Table 65. Meihua Group Company Information Table 66. Meihua Group Business Overview Table 67. Meihua Group Biomanufacturing in Bio-based Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Meihua Group Biomanufacturing in Bio-based Materials Product Portfolio Table 69. Meihua Group Recent Development Table 70. Bloomage Biotech Company Information Table 71. Bloomage Biotech Business Overview Table 72. Bloomage Biotech Biomanufacturing in Bio-based Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Bloomage Biotech Biomanufacturing in Bio-based Materials Product Portfolio Table 74. Bloomage Biotech Recent Development Table 75. Anhui BBCA Group Company Information Table 76. Anhui BBCA Group Business Overview Table 77. Anhui BBCA Group Biomanufacturing in Bio-based Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Anhui BBCA Group Biomanufacturing in Bio-based Materials Product Portfolio Table 79. Anhui BBCA Group Recent Development Table 80. Lushang Freda Company Information Table 81. Lushang Freda Business Overview Table 82. Lushang Freda Biomanufacturing in Bio-based Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Lushang Freda Biomanufacturing in Bio-based Materials Product Portfolio Table 84. Lushang Freda Recent Development Table 85. Total Corbion Company Information Table 86. Total Corbion Business Overview Table 87. Total Corbion Biomanufacturing in Bio-based Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Total Corbion Biomanufacturing in Bio-based Materials Product Portfolio Table 89. Total Corbion Recent Development Table 90. Zhejiang Hisun Biomaterials Company Information Table 91. Zhejiang Hisun Biomaterials Business Overview Table 92. Zhejiang Hisun Biomaterials Biomanufacturing in Bio-based Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Zhejiang Hisun Biomaterials Biomanufacturing in Bio-based Materials Product Portfolio Table 94. Zhejiang Hisun Biomaterials Recent Development Table 95. Pharmacosmos A/S Company Information Table 96. Pharmacosmos A/S Business Overview Table 97. Pharmacosmos A/S Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Pharmacosmos A/S Biomanufacturing in Bio-based Materials Product Portfolio Table 99. Pharmacosmos A/S Recent Development Table 100. Danimer Scientific Company Information Table 101. Danimer Scientific Business Overview Table 102. Danimer Scientific Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Danimer Scientific Biomanufacturing in Bio-based Materials Product Portfolio Table 104. Danimer Scientific Recent Development Table 105. Kingfa Sci.&Tech Company Information Table 106. Kingfa Sci.&Tech Business Overview Table 107. Kingfa Sci.&Tech Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Kingfa Sci.&Tech Biomanufacturing in Bio-based Materials Product Portfolio Table 109. Kingfa Sci.&Tech Recent Development Table 110. Kewpie Corporation Company Information Table 111. Kewpie Corporation Business Overview Table 112. Kewpie Corporation Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Kewpie Corporation Biomanufacturing in Bio-based Materials Product Portfolio Table 114. Kewpie Corporation Recent Development Table 115. Vedan Biotechnology Company Information Table 116. Vedan Biotechnology Business Overview Table 117. Vedan Biotechnology Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Vedan Biotechnology Biomanufacturing in Bio-based Materials Product Portfolio Table 119. Vedan Biotechnology Recent Development Table 120. Giant Biogene Company Information Table 121. Giant Biogene Business Overview Table 122. Giant Biogene Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Giant Biogene Biomanufacturing in Bio-based Materials Product Portfolio Table 124. Giant Biogene Recent Development Table 125. Contipro Inc. Company Information Table 126. Contipro Inc. Business Overview Table 127. Contipro Inc. Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Contipro Inc. Biomanufacturing in Bio-based Materials Product Portfolio Table 129. Contipro Inc. Recent Development Table 130. Shandong Topscience Biotech Company Information Table 131. Shandong Topscience Biotech Business Overview Table 132. Shandong Topscience Biotech Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Shandong Topscience Biotech Biomanufacturing in Bio-based Materials Product Portfolio Table 134. Shandong Topscience Biotech Recent Development Table 135. Blue Ridge Tunhe Company Information Table 136. Blue Ridge Tunhe Business Overview Table 137. Blue Ridge Tunhe Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Blue Ridge Tunhe Biomanufacturing in Bio-based Materials Product Portfolio Table 139. Blue Ridge Tunhe Recent Development Table 140. JNC Corporation Company Information Table 141. JNC Corporation Business Overview Table 142. JNC Corporation Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. JNC Corporation Biomanufacturing in Bio-based Materials Product Portfolio Table 144. JNC Corporation Recent Development Table 145. NAGASE Company Information Table 146. NAGASE Business Overview Table 147. NAGASE Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. NAGASE Biomanufacturing in Bio-based Materials Product Portfolio Table 149. NAGASE Recent Development Table 150. CJ Bio Company Information Table 151. CJ Bio Business Overview Table 152. CJ Bio Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 153. CJ Bio Biomanufacturing in Bio-based Materials Product Portfolio Table 154. CJ Bio Recent Development Table 155. Bluepha Company Information Table 156. Bluepha Business Overview Table 157. Bluepha Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 158. Bluepha Biomanufacturing in Bio-based Materials Product Portfolio Table 159. Bluepha Recent Development Table 160. Givaudan Company Information Table 161. Givaudan Business Overview Table 162. Givaudan Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 163. Givaudan Biomanufacturing in Bio-based Materials Product Portfolio Table 164. Givaudan Recent Development Table 165. RWDC Industries Company Information Table 166. RWDC Industries Business Overview Table 167. RWDC Industries Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 168. RWDC Industries Biomanufacturing in Bio-based Materials Product Portfolio Table 169. RWDC Industries Recent Development Table 170. Toyobo Company Information Table 171. Toyobo Business Overview Table 172. Toyobo Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 173. Toyobo Biomanufacturing in Bio-based Materials Product Portfolio Table 174. Toyobo Recent Development Table 175. PTT MCC Biochem Company Information Table 176. PTT MCC Biochem Business Overview Table 177. PTT MCC Biochem Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 178. PTT MCC Biochem Biomanufacturing in Bio-based Materials Product Portfolio Table 179. PTT MCC Biochem Recent Development Table 180. TianAn Biologic Materials Co Company Information Table 181. TianAn Biologic Materials Co Business Overview Table 182. TianAn Biologic Materials Co Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 183. TianAn Biologic Materials Co Biomanufacturing in Bio-based Materials Product Portfolio Table 184. TianAn Biologic Materials Co Recent Development Table 185. Kaneka Company Information Table 186. Kaneka Business Overview Table 187. Kaneka Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 188. Kaneka Biomanufacturing in Bio-based Materials Product Portfolio Table 189. Kaneka Recent Development Table 190. Jiangsu JLand Biotech Company Information Table 191. Jiangsu JLand Biotech Business Overview Table 192. Jiangsu JLand Biotech Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 193. Jiangsu JLand Biotech Biomanufacturing in Bio-based Materials Product Portfolio Table 194. Jiangsu JLand Biotech Recent Development Table 195. Jiangsu Chuangjian Medical Technology Company Information Table 196. Jiangsu Chuangjian Medical Technology Business Overview Table 197. Jiangsu Chuangjian Medical Technology Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 198. Jiangsu Chuangjian Medical Technology Biomanufacturing in Bio-based Materials Product Portfolio Table 199. Jiangsu Chuangjian Medical Technology Recent Development Table 200. Cathay Biotech Inc. Company Information Table 201. Cathay Biotech Inc. Business Overview Table 202. Cathay Biotech Inc. Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 203. Cathay Biotech Inc. Biomanufacturing in Bio-based Materials Product Portfolio Table 204. Cathay Biotech Inc. Recent Development Table 205. Zhejiang Shengda Bio-Pharm Company Information Table 206. Zhejiang Shengda Bio-Pharm Business Overview Table 207. Zhejiang Shengda Bio-Pharm Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 208. Zhejiang Shengda Bio-Pharm Biomanufacturing in Bio-based Materials Product Portfolio Table 209. Zhejiang Shengda Bio-Pharm Recent Development Table 210. DANCHENG CAIXIN SUGAR INDUSTRY Company Information Table 211. DANCHENG CAIXIN SUGAR INDUSTRY Business Overview Table 212. DANCHENG CAIXIN SUGAR INDUSTRY Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 213. DANCHENG CAIXIN SUGAR INDUSTRY Biomanufacturing in Bio-based Materials Product Portfolio Table 214. DANCHENG CAIXIN SUGAR INDUSTRY Recent Development Table 215. CanSinoBIO Company Information Table 216. CanSinoBIO Business Overview Table 217. CanSinoBIO Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 218. CanSinoBIO Biomanufacturing in Bio-based Materials Product Portfolio Table 219. CanSinoBIO Recent Development Table 220. AMSilk GmbH Company Information Table 221. AMSilk GmbH Business Overview Table 222. AMSilk GmbH Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 223. AMSilk GmbH Biomanufacturing in Bio-based Materials Product Portfolio Table 224. AMSilk GmbH Recent Development Table 225. Shandong AWA Biopharm Company Information Table 226. Shandong AWA Biopharm Business Overview Table 227. Shandong AWA Biopharm Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 228. Shandong AWA Biopharm Biomanufacturing in Bio-based Materials Product Portfolio Table 229. Shandong AWA Biopharm Recent Development Table 230. Shandong Mimei Biotechnology Company Information Table 231. Shandong Mimei Biotechnology Business Overview Table 232. Shandong Mimei Biotechnology Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 233. Shandong Mimei Biotechnology Biomanufacturing in Bio-based Materials Product Portfolio Table 234. Shandong Mimei Biotechnology Recent Development Table 235. Juyou Bio-Technology Company Information Table 236. Juyou Bio-Technology Business Overview Table 237. Juyou Bio-Technology Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 238. Juyou Bio-Technology Biomanufacturing in Bio-based Materials Product Portfolio Table 239. Juyou Bio-Technology Recent Development Table 240. Shanghai Techwell Biopharmacieutical Company Information Table 241. Shanghai Techwell Biopharmacieutical Business Overview Table 242. Shanghai Techwell Biopharmacieutical Biomanufacturing in Bio-based Materials Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 243. Shanghai Techwell Biopharmacieutical Biomanufacturing in Bio-based Materials Product Portfolio Table 244. Shanghai Techwell Biopharmacieutical Recent Development Table 245. Research Programs/Design for This Report Table 246. Authors List of This Report Table 247. Secondary Sources Table 248. Primary Sources List of Figures Figure 1. Biomanufacturing in Bio-based Materials Product Image Figure 2. Global Biomanufacturing in Bio-based Materials Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biomanufacturing in Bio-based Materials Market Size (2021-2032) & (US$ Million) Figure 4. Global Biomanufacturing in Bio-based Materials Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Polysaccharide Polymers Image Figure 8. Protein Polymers Image Figure 9. Polyester Polymers Image Figure 10. Others Image Figure 11. Global Biomanufacturing in Bio-based Materials Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Biomanufacturing in Bio-based Materials Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Biomanufacturing in Bio-based Materials Sales Value Share by Type (2021-2032) Figure 14. Food & Beverage Image Figure 15. Daily Chemicals Image Figure 16. Medical Image Figure 17. Packaging Image Figure 18. Textiles Image Figure 19. Automotive Industry Image Figure 20. Other Image Figure 21. Global Biomanufacturing in Bio-based Materials Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Biomanufacturing in Bio-based Materials Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global Biomanufacturing in Bio-based Materials Sales Value Share by Application (2021-2032) Figure 24. Global Biomanufacturing in Bio-based Materials Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 25. Global Biomanufacturing in Bio-based Materials Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 26. North America Biomanufacturing in Bio-based Materials Sales Value (2021-2032) & (US$ Million) Figure 27. North America Biomanufacturing in Bio-based Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Europe Biomanufacturing in Bio-based Materials Sales Value (2021-2032) & (US$ Million) Figure 29. Europe Biomanufacturing in Bio-based Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Asia-Pacific Biomanufacturing in Bio-based Materials Sales Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific Biomanufacturing in Bio-based Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 32. South America Biomanufacturing in Bio-based Materials Sales Value (2021-2032) & (US$ Million) Figure 33. South America Biomanufacturing in Bio-based Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Middle East & Africa Biomanufacturing in Bio-based Materials Sales Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa Biomanufacturing in Bio-based Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 36. USA Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. USA Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. USA Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Canada Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Canada Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Canada Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Mexico Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Mexico Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Mexico Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Germany Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Germany Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Germany Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. France Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. France Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. France Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. U.K. Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. U.K. Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. U.K. Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Italy Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Italy Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Italy Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Spain Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Spain Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Spain Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Russia Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Russia Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Russia Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Netherlands Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Netherlands Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Netherlands Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Nordic Countries Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Nordic Countries Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Nordic Countries Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. China Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. China Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. China Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Japan Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Japan Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Japan Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. South Korea Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. South Korea Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. South Korea Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. India Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. India Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. India Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Australia Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Australia Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Australia Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Southeast Asia Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Southeast Asia Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Southeast Asia Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Brazil Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Brazil Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Brazil Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Argentina Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Argentina Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Argentina Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Chile Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Chile Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Chile Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Colombia Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Colombia Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Colombia Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Peru Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Peru Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Peru Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Saudi Arabia Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Saudi Arabia Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Israel Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Israel Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Israel Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. UAE Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. UAE Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. UAE Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Turkey Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Turkey Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Turkey Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Iran Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Iran Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Iran Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Egypt Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Egypt Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Egypt Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Years Considered Figure 121. Research Process Figure

Scope & coverage.

Types
  • Polysaccharide Polymers
  • Protein Polymers
  • Polyester Polymers
  • Others
Applications
  • Food & Beverage
  • Daily Chemicals
  • Medical
  • Packaging
  • Textiles
  • Automotive Industry
  • Other
Companies covered
  • Braskem
  • NatureWorks
  • Tate & Lyle
  • Fufeng Group
  • Meihua Group
  • Bloomage Biotech
  • Anhui BBCA Group
  • Lushang Freda
  • Total Corbion
  • Zhejiang Hisun Biomaterials
  • Pharmacosmos A/S
  • Danimer Scientific
  • Kingfa Sci.&Tech
  • Kewpie Corporation
  • Vedan Biotechnology
  • Giant Biogene
  • Contipro Inc.
  • Shandong Topscience Biotech
  • Blue Ridge Tunhe
  • JNC Corporation
  • NAGASE
  • CJ Bio
  • Bluepha
  • Givaudan
  • RWDC Industries
  • Toyobo
  • PTT MCC Biochem
  • TianAn Biologic Materials Co
  • Kaneka
  • Jiangsu JLand Biotech
  • Jiangsu Chuangjian Medical Technology
  • Cathay Biotech Inc.
  • Zhejiang Shengda Bio-Pharm
  • DANCHENG CAIXIN SUGAR INDUSTRY
  • CanSinoBIO
  • AMSilk GmbH
  • Shandong AWA Biopharm
  • Shandong Mimei Biotechnology
  • Juyou Bio-Technology
  • Shanghai Techwell Biopharmacieutical
  • Jinpu Nuoan Biotechnology
  • Jinyang Pharmaceutical
  • Ningxia Eppen Biotech
  • Kuraray
  • Shanxi Jinbo Bio-pharmaceutical
  • Wuhu Interferon
  • Evonik
  • TS-Biotech
  • Nanjing XuanKai Biotechnology
  • HTL Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biomanufacturing in Bio-based Materials Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biomanufacturing in Bio-based Materials Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biomanufacturing in Bio-based Materials Market Dynamics
  1. 2.1 Biomanufacturing in Bio-based Materials Industry Trends
  2. 2.2 Biomanufacturing in Bio-based Materials Industry Drivers
  3. 2.3 Biomanufacturing in Bio-based Materials Industry Opportunities and Challenges
  4. 2.4 Biomanufacturing in Bio-based Materials Industry Restraints
3 Biomanufacturing in Bio-based Materials Market by Company
  1. 3.1 Global Biomanufacturing in Bio-based Materials Company Revenue Ranking in 2025
  2. 3.2 Global Biomanufacturing in Bio-based Materials Revenue by Company (2021-2026)
  3. 3.3 Global Biomanufacturing in Bio-based Materials Company Ranking (2024-2026)
  4. 3.4 Global Biomanufacturing in Bio-based Materials Company Manufacturing Base and Headquarters
  5. 3.5 Global Biomanufacturing in Bio-based Materials Company Product Type and Application
  6. 3.6 Global Biomanufacturing in Bio-based Materials Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biomanufacturing in Bio-based Materials Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biomanufacturing in Bio-based Materials Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biomanufacturing in Bio-based Materials Market by Type
  1. 4.1 Biomanufacturing in Bio-based Materials Type Introduction
  2. 4.1.1 Polysaccharide Polymers
  3. 4.1.2 Protein Polymers
  4. 4.1.3 Polyester Polymers
  5. 4.1.4 Others
  6. 4.2 Global Biomanufacturing in Bio-based Materials Sales Value by Type
  7. 4.2.1 Global Biomanufacturing in Bio-based Materials Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Biomanufacturing in Bio-based Materials Sales Value by Type (2021-2032)
  9. 4.2.3 Global Biomanufacturing in Bio-based Materials Sales Value Share by Type (2021-2032)
5 Biomanufacturing in Bio-based Materials Market by Application
  1. 5.1 Biomanufacturing in Bio-based Materials Application Introduction
  2. 5.1.1 Food & Beverage
  3. 5.1.2 Daily Chemicals
  4. 5.1.3 Medical
  5. 5.1.4 Packaging
  6. 5.1.5 Textiles
  7. 5.1.6 Automotive Industry
  8. 5.1.7 Other
  9. 5.2 Global Biomanufacturing in Bio-based Materials Sales Value by Application
  10. 5.2.1 Global Biomanufacturing in Bio-based Materials Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.2.2 Global Biomanufacturing in Bio-based Materials Sales Value by Application (2021-2032)
  12. 5.2.3 Global Biomanufacturing in Bio-based Materials Sales Value Share by Application (2021-2032)
6 Biomanufacturing in Bio-based Materials Regional Value Analysis
  1. 6.1 Global Biomanufacturing in Bio-based Materials Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biomanufacturing in Bio-based Materials Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biomanufacturing in Bio-based Materials Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biomanufacturing in Bio-based Materials Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biomanufacturing in Bio-based Materials Sales Value (2021-2032)
  7. 6.3.2 North America Biomanufacturing in Bio-based Materials Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biomanufacturing in Bio-based Materials Sales Value (2021-2032)
  10. 6.4.2 Europe Biomanufacturing in Bio-based Materials Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biomanufacturing in Bio-based Materials Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biomanufacturing in Bio-based Materials Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biomanufacturing in Bio-based Materials Sales Value (2021-2032)
  16. 6.6.2 South America Biomanufacturing in Bio-based Materials Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biomanufacturing in Bio-based Materials Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biomanufacturing in Bio-based Materials Sales Value Share by Country, 2025 VS 2032
7 Biomanufacturing in Bio-based Materials Country-level Value Analysis
  1. 7.1 Global Biomanufacturing in Bio-based Materials Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biomanufacturing in Bio-based Materials Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biomanufacturing in Bio-based Materials Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biomanufacturing in Bio-based Materials Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biomanufacturing in Bio-based Materials Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biomanufacturing in Bio-based Materials Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biomanufacturing in Bio-based Materials Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Braskem
  2. 8.1.1 Braskem Company Information
  3. 8.1.2 Braskem Business Overview
  4. 8.1.3 Braskem Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Braskem Biomanufacturing in Bio-based Materials Product Portfolio
  6. 8.1.5 Braskem Recent Developments
  7. 8.2 NatureWorks
  8. 8.2.1 NatureWorks Company Information
  9. 8.2.2 NatureWorks Business Overview
  10. 8.2.3 NatureWorks Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  11. 8.2.4 NatureWorks Biomanufacturing in Bio-based Materials Product Portfolio
  12. 8.2.5 NatureWorks Recent Developments
  13. 8.3 Tate & Lyle
  14. 8.3.1 Tate & Lyle Company Information
  15. 8.3.2 Tate & Lyle Business Overview
  16. 8.3.3 Tate & Lyle Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tate & Lyle Biomanufacturing in Bio-based Materials Product Portfolio
  18. 8.3.5 Tate & Lyle Recent Developments
  19. 8.4 Fufeng Group
  20. 8.4.1 Fufeng Group Company Information
  21. 8.4.2 Fufeng Group Business Overview
  22. 8.4.3 Fufeng Group Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fufeng Group Biomanufacturing in Bio-based Materials Product Portfolio
  24. 8.4.5 Fufeng Group Recent Developments
  25. 8.5 Meihua Group
  26. 8.5.1 Meihua Group Company Information
  27. 8.5.2 Meihua Group Business Overview
  28. 8.5.3 Meihua Group Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Meihua Group Biomanufacturing in Bio-based Materials Product Portfolio
  30. 8.5.5 Meihua Group Recent Developments
  31. 8.6 Bloomage Biotech
  32. 8.6.1 Bloomage Biotech Company Information
  33. 8.6.2 Bloomage Biotech Business Overview
  34. 8.6.3 Bloomage Biotech Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bloomage Biotech Biomanufacturing in Bio-based Materials Product Portfolio
  36. 8.6.5 Bloomage Biotech Recent Developments
  37. 8.7 Anhui BBCA Group
  38. 8.7.1 Anhui BBCA Group Company Information
  39. 8.7.2 Anhui BBCA Group Business Overview
  40. 8.7.3 Anhui BBCA Group Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Anhui BBCA Group Biomanufacturing in Bio-based Materials Product Portfolio
  42. 8.7.5 Anhui BBCA Group Recent Developments
  43. 8.8 Lushang Freda
  44. 8.8.1 Lushang Freda Company Information
  45. 8.8.2 Lushang Freda Business Overview
  46. 8.8.3 Lushang Freda Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lushang Freda Biomanufacturing in Bio-based Materials Product Portfolio
  48. 8.8.5 Lushang Freda Recent Developments
  49. 8.9 Total Corbion
  50. 8.9.1 Total Corbion Company Information
  51. 8.9.2 Total Corbion Business Overview
  52. 8.9.3 Total Corbion Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Total Corbion Biomanufacturing in Bio-based Materials Product Portfolio
  54. 8.9.5 Total Corbion Recent Developments
  55. 8.10 Zhejiang Hisun Biomaterials
  56. 8.10.1 Zhejiang Hisun Biomaterials Company Information
  57. 8.10.2 Zhejiang Hisun Biomaterials Business Overview
  58. 8.10.3 Zhejiang Hisun Biomaterials Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Zhejiang Hisun Biomaterials Biomanufacturing in Bio-based Materials Product Portfolio
  60. 8.10.5 Zhejiang Hisun Biomaterials Recent Developments
  61. 8.11 Pharmacosmos A/S
  62. 8.11.1 Pharmacosmos A/S Company Information
  63. 8.11.2 Pharmacosmos A/S Business Overview
  64. 8.11.3 Pharmacosmos A/S Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pharmacosmos A/S Biomanufacturing in Bio-based Materials Product Portfolio
  66. 8.11.5 Pharmacosmos A/S Recent Developments
  67. 8.12 Danimer Scientific
  68. 8.12.1 Danimer Scientific Company Information
  69. 8.12.2 Danimer Scientific Business Overview
  70. 8.12.3 Danimer Scientific Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Danimer Scientific Biomanufacturing in Bio-based Materials Product Portfolio
  72. 8.12.5 Danimer Scientific Recent Developments
  73. 8.13 Kingfa Sci.&Tech
  74. 8.13.1 Kingfa Sci.&Tech Company Information
  75. 8.13.2 Kingfa Sci.&Tech Business Overview
  76. 8.13.3 Kingfa Sci.&Tech Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Kingfa Sci.&Tech Biomanufacturing in Bio-based Materials Product Portfolio
  78. 8.13.5 Kingfa Sci.&Tech Recent Developments
  79. 8.14 Kewpie Corporation
  80. 8.14.1 Kewpie Corporation Company Information
  81. 8.14.2 Kewpie Corporation Business Overview
  82. 8.14.3 Kewpie Corporation Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Kewpie Corporation Biomanufacturing in Bio-based Materials Product Portfolio
  84. 8.14.5 Kewpie Corporation Recent Developments
  85. 8.15 Vedan Biotechnology
  86. 8.15.1 Vedan Biotechnology Company Information
  87. 8.15.2 Vedan Biotechnology Business Overview
  88. 8.15.3 Vedan Biotechnology Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Vedan Biotechnology Biomanufacturing in Bio-based Materials Product Portfolio
  90. 8.15.5 Vedan Biotechnology Recent Developments
  91. 8.16 Giant Biogene
  92. 8.16.1 Giant Biogene Company Information
  93. 8.16.2 Giant Biogene Business Overview
  94. 8.16.3 Giant Biogene Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Giant Biogene Biomanufacturing in Bio-based Materials Product Portfolio
  96. 8.16.5 Giant Biogene Recent Developments
  97. 8.17 Contipro Inc.
  98. 8.17.1 Contipro Inc. Company Information
  99. 8.17.2 Contipro Inc. Business Overview
  100. 8.17.3 Contipro Inc. Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Contipro Inc. Biomanufacturing in Bio-based Materials Product Portfolio
  102. 8.17.5 Contipro Inc. Recent Developments
  103. 8.18 Shandong Topscience Biotech
  104. 8.18.1 Shandong Topscience Biotech Company Information
  105. 8.18.2 Shandong Topscience Biotech Business Overview
  106. 8.18.3 Shandong Topscience Biotech Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Shandong Topscience Biotech Biomanufacturing in Bio-based Materials Product Portfolio
  108. 8.18.5 Shandong Topscience Biotech Recent Developments
  109. 8.19 Blue Ridge Tunhe
  110. 8.19.1 Blue Ridge Tunhe Company Information
  111. 8.19.2 Blue Ridge Tunhe Business Overview
  112. 8.19.3 Blue Ridge Tunhe Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Blue Ridge Tunhe Biomanufacturing in Bio-based Materials Product Portfolio
  114. 8.19.5 Blue Ridge Tunhe Recent Developments
  115. 8.20 JNC Corporation
  116. 8.20.1 JNC Corporation Company Information
  117. 8.20.2 JNC Corporation Business Overview
  118. 8.20.3 JNC Corporation Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  119. 8.20.4 JNC Corporation Biomanufacturing in Bio-based Materials Product Portfolio
  120. 8.20.5 JNC Corporation Recent Developments
  121. 8.21 NAGASE
  122. 8.21.1 NAGASE Company Information
  123. 8.21.2 NAGASE Business Overview
  124. 8.21.3 NAGASE Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  125. 8.21.4 NAGASE Biomanufacturing in Bio-based Materials Product Portfolio
  126. 8.21.5 NAGASE Recent Developments
  127. 8.22 CJ Bio
  128. 8.22.1 CJ Bio Company Information
  129. 8.22.2 CJ Bio Business Overview
  130. 8.22.3 CJ Bio Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  131. 8.22.4 CJ Bio Biomanufacturing in Bio-based Materials Product Portfolio
  132. 8.22.5 CJ Bio Recent Developments
  133. 8.23 Bluepha
  134. 8.23.1 Bluepha Company Information
  135. 8.23.2 Bluepha Business Overview
  136. 8.23.3 Bluepha Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Bluepha Biomanufacturing in Bio-based Materials Product Portfolio
  138. 8.23.5 Bluepha Recent Developments
  139. 8.24 Givaudan
  140. 8.24.1 Givaudan Company Information
  141. 8.24.2 Givaudan Business Overview
  142. 8.24.3 Givaudan Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Givaudan Biomanufacturing in Bio-based Materials Product Portfolio
  144. 8.24.5 Givaudan Recent Developments
  145. 8.25 RWDC Industries
  146. 8.25.1 RWDC Industries Company Information
  147. 8.25.2 RWDC Industries Business Overview
  148. 8.25.3 RWDC Industries Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  149. 8.25.4 RWDC Industries Biomanufacturing in Bio-based Materials Product Portfolio
  150. 8.25.5 RWDC Industries Recent Developments
  151. 8.26 Toyobo
  152. 8.26.1 Toyobo Company Information
  153. 8.26.2 Toyobo Business Overview
  154. 8.26.3 Toyobo Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Toyobo Biomanufacturing in Bio-based Materials Product Portfolio
  156. 8.26.5 Toyobo Recent Developments
  157. 8.27 PTT MCC Biochem
  158. 8.27.1 PTT MCC Biochem Company Information
  159. 8.27.2 PTT MCC Biochem Business Overview
  160. 8.27.3 PTT MCC Biochem Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  161. 8.27.4 PTT MCC Biochem Biomanufacturing in Bio-based Materials Product Portfolio
  162. 8.27.5 PTT MCC Biochem Recent Developments
  163. 8.28 TianAn Biologic Materials Co
  164. 8.28.1 TianAn Biologic Materials Co Company Information
  165. 8.28.2 TianAn Biologic Materials Co Business Overview
  166. 8.28.3 TianAn Biologic Materials Co Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  167. 8.28.4 TianAn Biologic Materials Co Biomanufacturing in Bio-based Materials Product Portfolio
  168. 8.28.5 TianAn Biologic Materials Co Recent Developments
  169. 8.29 Kaneka
  170. 8.29.1 Kaneka Company Information
  171. 8.29.2 Kaneka Business Overview
  172. 8.29.3 Kaneka Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Kaneka Biomanufacturing in Bio-based Materials Product Portfolio
  174. 8.29.5 Kaneka Recent Developments
  175. 8.30 Jiangsu JLand Biotech
  176. 8.30.1 Jiangsu JLand Biotech Company Information
  177. 8.30.2 Jiangsu JLand Biotech Business Overview
  178. 8.30.3 Jiangsu JLand Biotech Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Jiangsu JLand Biotech Biomanufacturing in Bio-based Materials Product Portfolio
  180. 8.30.5 Jiangsu JLand Biotech Recent Developments
  181. 8.31 Jiangsu Chuangjian Medical Technology
  182. 8.31.1 Jiangsu Chuangjian Medical Technology Company Information
  183. 8.31.2 Jiangsu Chuangjian Medical Technology Business Overview
  184. 8.31.3 Jiangsu Chuangjian Medical Technology Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  185. 8.31.4 Jiangsu Chuangjian Medical Technology Biomanufacturing in Bio-based Materials Product Portfolio
  186. 8.31.5 Jiangsu Chuangjian Medical Technology Recent Developments
  187. 8.32 Cathay Biotech Inc.
  188. 8.32.1 Cathay Biotech Inc. Company Information
  189. 8.32.2 Cathay Biotech Inc. Business Overview
  190. 8.32.3 Cathay Biotech Inc. Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  191. 8.32.4 Cathay Biotech Inc. Biomanufacturing in Bio-based Materials Product Portfolio
  192. 8.32.5 Cathay Biotech Inc. Recent Developments
  193. 8.33 Zhejiang Shengda Bio-Pharm
  194. 8.33.1 Zhejiang Shengda Bio-Pharm Company Information
  195. 8.33.2 Zhejiang Shengda Bio-Pharm Business Overview
  196. 8.33.3 Zhejiang Shengda Bio-Pharm Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  197. 8.33.4 Zhejiang Shengda Bio-Pharm Biomanufacturing in Bio-based Materials Product Portfolio
  198. 8.33.5 Zhejiang Shengda Bio-Pharm Recent Developments
  199. 8.34 DANCHENG CAIXIN SUGAR INDUSTRY
  200. 8.34.1 DANCHENG CAIXIN SUGAR INDUSTRY Company Information
  201. 8.34.2 DANCHENG CAIXIN SUGAR INDUSTRY Business Overview
  202. 8.34.3 DANCHENG CAIXIN SUGAR INDUSTRY Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  203. 8.34.4 DANCHENG CAIXIN SUGAR INDUSTRY Biomanufacturing in Bio-based Materials Product Portfolio
  204. 8.34.5 DANCHENG CAIXIN SUGAR INDUSTRY Recent Developments
  205. 8.35 CanSinoBIO
  206. 8.35.1 CanSinoBIO Company Information
  207. 8.35.2 CanSinoBIO Business Overview
  208. 8.35.3 CanSinoBIO Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  209. 8.35.4 CanSinoBIO Biomanufacturing in Bio-based Materials Product Portfolio
  210. 8.35.5 CanSinoBIO Recent Developments
  211. 8.36 AMSilk GmbH
  212. 8.36.1 AMSilk GmbH Company Information
  213. 8.36.2 AMSilk GmbH Business Overview
  214. 8.36.3 AMSilk GmbH Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  215. 8.36.4 AMSilk GmbH Biomanufacturing in Bio-based Materials Product Portfolio
  216. 8.36.5 AMSilk GmbH Recent Developments
  217. 8.37 Shandong AWA Biopharm
  218. 8.37.1 Shandong AWA Biopharm Company Information
  219. 8.37.2 Shandong AWA Biopharm Business Overview
  220. 8.37.3 Shandong AWA Biopharm Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  221. 8.37.4 Shandong AWA Biopharm Biomanufacturing in Bio-based Materials Product Portfolio
  222. 8.37.5 Shandong AWA Biopharm Recent Developments
  223. 8.38 Shandong Mimei Biotechnology
  224. 8.38.1 Shandong Mimei Biotechnology Company Information
  225. 8.38.2 Shandong Mimei Biotechnology Business Overview
  226. 8.38.3 Shandong Mimei Biotechnology Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  227. 8.38.4 Shandong Mimei Biotechnology Biomanufacturing in Bio-based Materials Product Portfolio
  228. 8.38.5 Shandong Mimei Biotechnology Recent Developments
  229. 8.39 Juyou Bio-Technology
  230. 8.39.1 Juyou Bio-Technology Company Information
  231. 8.39.2 Juyou Bio-Technology Business Overview
  232. 8.39.3 Juyou Bio-Technology Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  233. 8.39.4 Juyou Bio-Technology Biomanufacturing in Bio-based Materials Product Portfolio
  234. 8.39.5 Juyou Bio-Technology Recent Developments
  235. 8.40 Shanghai Techwell Biopharmacieutical
  236. 8.40.1 Shanghai Techwell Biopharmacieutical Company Information
  237. 8.40.2 Shanghai Techwell Biopharmacieutical Business Overview
  238. 8.40.3 Shanghai Techwell Biopharmacieutical Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
  239. 8.40.4 Shanghai Techwell Biopharmacieutical Biomanufacturing in Bio-based Materials Product Portfolio
  240. 8.40.5 Shanghai Techwell Biopharmacieutical Recent Developments
  241. 8.41 Jinpu Nuoan Biotechnology
  242. 8.42 Jinyang Pharmaceutical
  243. 8.43 Ningxia Eppen Biotech
  244. 8.44 Kuraray
  245. 8.45 Shanxi Jinbo Bio-pharmaceutical
  246. 8.46 Wuhu Interferon
  247. 8.47 Evonik
  248. 8.48 TS-Biotech
  249. 8.49 Nanjing XuanKai Biotechnology
  250. 8.50 HTL Biotechnology
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst